Abstract

Low prevalence of <scp>IgG</scp> antibodies to <scp>SARS‐CoV</scp>‐2 in cancer patients with <scp>COVID</scp>‐19

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call